Infections and immunoepidemiology branch (IIB) & integrative tumor epidemiology branch (iteb) support services
Active Awarded Last action
- Contract number
- 75N91024F00001
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,175,391
Award facts
- Contract value 28% obligated
-
- $13,146,691.00 Current, with exercised options
- $32,485,777.00 Potential, with all options
- Completion date 35% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,931,351 | |
| Exercise an Option | $2,806,622 | |
| Change Order | $0 | |
| Exercise an Option | $1,648,358 | |
| Original award | $1,789,060 |
About this award
The National Cancer Institute issued a delivery order to Westat, Inc. on March 1, 2024, with a ceiling value of $32.49 million under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services parent IDIQ, supporting field and biospecimen operations for the Infections and Immunoepidemiology Branch and Integrative Tumor Epidemiology Branch through September 19, 2031.
Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with no set-aside. Service Contract Inventory data shows actual government-invoiced labor of $1.4 million in FY2024 (3.7 FTEs, 7,595 contractor hours at a derived rate of $187.84/hr) and $2.2 million in FY2025 (3.8 FTEs). Westat self-performed all reported hours in FY2025 with no subcontractors.
Quick answers
Who was awarded contract 75N91024F00001?
75N91024F00001 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2024.
How much is contract 75N91024F00001 worth?
The government has obligated $9,175,391 on 75N91024F00001. Its current value, with exercised options, is $13,146,691. Its potential value, with all options, is $32,485,777.
Is contract 75N91024F00001 an order under another contract?
Yes. 75N91024F00001 is a delivery order under 75N91022D00006, an indefinite delivery contract, on Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services.
Was contract 75N91024F00001 competed?
The extent of competition for 75N91024F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award